Connect with us

Hi, what are you looking for?

Jewish Business News

Business

Pfizer’s talks to acquire Allergan in a $150 billion deal

Pfizer is negotiating a price of $370 to $380 for each share, a person familiar with the discussions said.

BILL ACKMAN screen shot

Pfizer’s talks to acquire Allergan in a $150 billion deal that would see the US drug giant redomicile in Ireland accelerated on Wednesday, as the US Treasury prepared to clamp down further on such tax inversions.

Pfizer is negotiating a price of $370 to $380 for each Allergan share, a person familiar with the discussions said, asking not to be identified because the talks are confidential. Allergan shares ended trading on Wednesday at $310.8 per share. While negotiations have made progress in recent days, an agreement is not imminent and its timing remains uncertain following the Treasury’s disclosure that it would seek to tighten the rules on inversions, the source added.

Read the full story at Money Control 

Newsletter



Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.